ADVANCING ORAL THERAPEUTICS TO TRANSFORM THE TREATMENT OF INFLAMMATION AND CANCER

RAPT Therapeutics is focused on the development of oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology. Utilizing our proprietary discovery engine, we are developing highly selective small molecules that are designed to modulate the critical immune responses underlying these diseases.